尼罗替尼 - CAS:641571-10-0 - 研锐化学-溶剂、试剂、原料、耗材、仪器、[研化商城]

尼罗替尼

英文名： Nilotinib 别名：尼罗替尼及其中间体;4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺;尼罗替尼;Nilotinib (AMN-107) 抑制剂;尼罗替尼尼洛替尼;尼罗替尼标准品;尼罗替尼碱;尼洛替尼;4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰;NILO锡IB;苯甲酰胺, 4-甲基-N-[3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基]-3-[[4-(3-吡啶基)-2-嘧啶基]氨基];尼罗替尼尼罗替尼(对照品)

商品编号：R017125-250mg 规格：250mg 纯度：98%

CAS号： 641571-10-0 分子式：C28H22F3N7O 分子量：529.52

价格	¥ 229.00 （请登录会员查看折扣价）
货期	现货

数量

中文名称：	尼罗替尼
中文别名：	尼罗替尼及其中间体;4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺;尼罗替尼;Nilotinib (AMN-107) 抑制剂;尼罗替尼尼洛替尼;尼罗替尼标准品;尼罗替尼碱;尼洛替尼;4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰;NILO锡IB;苯甲酰胺, 4-甲基-N-[3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯基]-3-[[4-(3-吡啶基)-2-嘧啶基]氨基];尼罗替尼尼罗替尼(对照品)
smiles：	FC(C1=C([H])C(=C([H])C(=C1[H])N1C([H])=NC(C([H])([H])[H])=C1[H])N([H])C(C1C([H])=C([H])C(C([H])([H])[H])=C(C=1[H])N([H])C1=NC([H])=C([H])C(C2=C([H])N=C([H])C([H])=C2[H])=N1)=O)(F)F
英文名称：	Nilotinib
英文别名：	Nilotinib;AMN 107;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide Nilotinib(TINIBS );4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide;Nilotinib for research;Tasigna;Nilotinib &its intermediates (Developing);Nilotinib (AMN-107);4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyrid...;Nilotinib (AMN-107,Tasigna®);Nilotinib(AMN 107);Posaconazole inter; Afatinib;AMN-107;BIBW2992;its intermediates;Nilotinib,AMN107,Tasigna;TASIGNA NILOTINIB;Nilotinib & its intermediates;Nilotinib & its intermediates;AMN107;4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;C28H22F3N7O;HHZIURLSWUIHRB-UHFFFAOYSA-N;NSC747599;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl;FT-0654026;NILOTINIB [MI];Nilotinib [USAN:INN:BAN];Z1741976994;HMS3748E11;CHEBI:52172;NCGC00183285-04;NILOTINIB [INN];HMS3244A14;F41401512X;EX-A8380;AB01273978-02;3gp0;D08953;Q-101348;NCGC00183285-03;4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide;UNII-F41401512X;Nilotinib,AMN107,Tasigna;4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide;NSC 747599;NILOTINIB (USP-RS);NILOTINIB [HSDB];BRD-K81528515-001-04-7;BN164654;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide;4-Methyl-N-[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino] benzamide;Nilotinib [USAN];AB01273978_03;NSC-800804;NSC800804;NILOTINIB [USP-RS];N-(3-(3-(1H-Imidazolyl)propoxy)phenyl)-4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide;Benzamide, 4-methyl-N-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-;641571-10-0;benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;BENZAMIDE, 4-METHYL-N-(3-(4-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)-;Nilotinib free base;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- (9CI);nilotinibum;4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-{(4-(pyridin-3-yl)pyrimidin-2-yl...
CAS号：	641571-10-0
分子式：	C28H22F3N7O
分子量：	529.52
密度：
熔点：
沸点：
闪点：
水溶性：
蒸气压：

搜索质检报告(COA)

搜索MSDS